User profiles for Harald Schrem

Harald Schrem

Medical University of Graz
Verified email at medunigraz.at
Cited by 4051

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression

H Schrem, J Klempnauer, J Borlak - Pharmacological reviews, 2002 - ASPET
Numerous studies have established the pivotal role of liver-enriched transcription factors in
organ development and cellular function, and there is conclusive evidence for transcription …

Liver transplantation after organ preservation with normothermic extracorporeal perfusion

MR Schön, O Kollmar, S Wolf, H Schrem… - Annals of …, 2001 - journals.lww.com
… MD,*; Kollmar, Otto MD,*; Wolf, Stephen MD,†; Schrem, Harald MD,*; Matthes, Monika MD,*;
Akkoc, Nermin MD,*; Schnoy, Norbert C. MD,‡; Neuhaus, and Peter MD* … Schön MR …

Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian …

H Schrem, J Klempnauer, J Borlak - Pharmacological reviews, 2004 - ASPET
In the first part of our review (see Pharmacol Rev 2002;54:129-158), we discussed the basic
principles of gene transcription and the complex interactions within the network of …

[PDF][PDF] Incidence and long‐term risk of de novo malignancies after liver transplantation with implications for prevention and detection

H Schrem, M Kurok, A Kaltenborn, A Vogel… - Liver …, 2013 - Wiley Online Library
The goal of this study was the characterization of long‐term cancer risks after liver
transplantation (LT) with implications for prevention and detection. Site‐specific cancer incidence …

[HTML][HTML] Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy

KJ Roberts, H Schrem, J Hodson, R Angelico… - Hpb, 2017 - Elsevier
Background Although many patients undergoing pancreatoduodenectomy (PD) for cancer
have pancreatic exocrine insufficiency, pancreatic enzyme replacement therapy (PERT) is not …

Mycophenolate mofetil in liver transplantation: a review.

A Kaltenborn, H Schrem - Annals of transplantation, 2013 - europepmc.org
Liver transplantation is the only live-saving, curative treatment for various end-stage liver
diseases, and it has excellent survival rates. Mycophenolate mofetil is widely used as co-…

Large-scale isolation of human hepatocytes for therapeutic application

…, HG Heuft, M Ott, M Winkler, H Schrem… - Cell …, 2005 - journals.sagepub.com
During the last decade, hepatocyte transplantation has been suggested as a safe and
potentially effective clinical option for the treatment of acute or decompensating chronic liver …

Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience

…, A Vogel, MD Jäger, H Schrem… - Journal of Hepato …, 2015 - Wiley Online Library
Intrahepatic cholangiocarcinoma is the second most common primary liver tumor. The aim
of this study was to analyze retrospectively the outcome of surgical treatment and prognostic …

Non‐melanoma skin cancer is reduced after switch of immunosuppression to mTOR‐inhibitors in organ transplant recipients

M Alter, I Satzger, H Schrem… - JDDG: Journal der …, 2014 - Wiley Online Library
Background Organ transplant recipients are prone to the development of non‐melanoma
skin cancer. Organ transplant recipients often develop multiple non‐melanoma skin cancers …

Magnetic resonance imaging of focal liver lesions: comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient

…, MG Mack, C Schimpfky, H Schrem… - Investigative …, 1996 - journals.lww.com
RATIONALE AND OBJECTIVES The authors assess the efficacy of static and dynamic
magnetic resonance (MR) imaging using the superparamagnetic iron oxide SHU-555A (Resovist®…